0.10Open0.10Pre Close0 Volume7 Open Interest7.00Strike Price0.00Turnover121.58%IV49.79%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier25DDays to Expiry0.10Extrinsic Value100Contract SizeAmericanOptions Type0.1468Delta0.1519Gamma47.40Leverage Ratio-0.0070Theta0.0004Rho6.96Eff Leverage0.0029Vega
CorMedix Stock Discussion
Dow Jones· 4 mins ago. CorMedix: DefenCath Catheter Lock Solution Is FDA Approved to Reduce Incidence of Catheter-Related Bloodstream Infections in Adult Patients With Kidney Failure >CRMD
Dow Jones· 2 mins ago
Benzinga· just
CorMedix Receives FDA Approval For Defencath - moomoo
No comment yet